NO20032218L - Eksoenzymtoksin fra Aeromonas salmonicida og anvendelse derav - Google Patents

Eksoenzymtoksin fra Aeromonas salmonicida og anvendelse derav

Info

Publication number
NO20032218L
NO20032218L NO20032218A NO20032218A NO20032218L NO 20032218 L NO20032218 L NO 20032218L NO 20032218 A NO20032218 A NO 20032218A NO 20032218 A NO20032218 A NO 20032218A NO 20032218 L NO20032218 L NO 20032218L
Authority
NO
Norway
Prior art keywords
exoenzyme
toxin
aeromonas salmonicida
salmonicida
aeromonas
Prior art date
Application number
NO20032218A
Other languages
English (en)
Other versions
NO335752B1 (no
NO20032218D0 (no
Inventor
Joachim Frey
Peter Kuhnert
Martin Braun
Julian C Thornton
Michael A Kuzik
Jan Burian
Original Assignee
Univ Bern
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Bern filed Critical Univ Bern
Publication of NO20032218D0 publication Critical patent/NO20032218D0/no
Publication of NO20032218L publication Critical patent/NO20032218L/no
Publication of NO335752B1 publication Critical patent/NO335752B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Public Health (AREA)
  • Pathology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cell Biology (AREA)
  • Veterinary Medicine (AREA)
  • Food Science & Technology (AREA)
  • Oncology (AREA)
  • Toxicology (AREA)
NO20032218A 2000-11-15 2003-05-15 Eksoenzymtoksin og nukleinsyrefragment fra Aeromonas salmonicida, vaksine og anvendelse derav samt fremgangsmåte for indusering av toksinet. NO335752B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US24886400P 2000-11-15 2000-11-15
PCT/CA2001/001600 WO2002040515A2 (en) 2000-11-15 2001-11-15 Exoenzyme toxin of aeromonas salmonicida, and uses thereof

Publications (3)

Publication Number Publication Date
NO20032218D0 NO20032218D0 (no) 2003-05-15
NO20032218L true NO20032218L (no) 2003-07-14
NO335752B1 NO335752B1 (no) 2015-02-02

Family

ID=22941002

Family Applications (3)

Application Number Title Priority Date Filing Date
NO20032217A NO335842B1 (no) 2000-11-15 2003-05-15 Aeromonas calcium respons D polypetid og isolert nukleinsyrefragment samt anvendelse av disse.
NO20032218A NO335752B1 (no) 2000-11-15 2003-05-15 Eksoenzymtoksin og nukleinsyrefragment fra Aeromonas salmonicida, vaksine og anvendelse derav samt fremgangsmåte for indusering av toksinet.
NO20141517A NO20141517L (no) 2000-11-15 2014-12-17 Ny type III-sekresjonsvei i Aeromonas salmonicida og anvendelse derav

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NO20032217A NO335842B1 (no) 2000-11-15 2003-05-15 Aeromonas calcium respons D polypetid og isolert nukleinsyrefragment samt anvendelse av disse.

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO20141517A NO20141517L (no) 2000-11-15 2014-12-17 Ny type III-sekresjonsvei i Aeromonas salmonicida og anvendelse derav

Country Status (6)

Country Link
US (6) US7351550B2 (no)
AU (2) AU2002214891A1 (no)
CA (4) CA2467309C (no)
GB (2) GB2389112A (no)
NO (3) NO335842B1 (no)
WO (2) WO2002040515A2 (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2054726B1 (en) * 2006-08-14 2010-10-27 BioControl Systems, Inc. Method for detecting listeria
US8716283B2 (en) 2007-11-07 2014-05-06 University Of Massachusetts Type III secretion inhibitors, analogs and uses thereof
WO2010135704A2 (en) * 2009-05-22 2010-11-25 Institute For Systems Biology Secretion-related bacterial proteins for nlrc4 stimulation
CN108251341B (zh) * 2018-03-27 2020-11-06 北京鼎持生物技术有限公司 一种铜绿假单胞菌以及含该菌的海洋哺乳动物疫苗
US12403187B2 (en) 2018-12-31 2025-09-02 Bellevacc As Bacterial vaccine
CN110922454B (zh) * 2019-12-05 2020-11-06 中国科学院深圳先进技术研究院 绿脓杆菌毒素ExoS和ExoT的免疫用途及其制备方法
US20230226175A1 (en) 2020-06-25 2023-07-20 Glaxosmithkline Biologicals Sa Modified exotoxin a proteins

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9112310D0 (en) 1991-06-07 1991-07-24 United Kingdom Government Fish vaccine
GB2308367B (en) 1995-12-22 1999-10-13 Scottish Salmon Growers Ass Aeromonas protein used as a vaccine component

Also Published As

Publication number Publication date
NO335752B1 (no) 2015-02-02
US20070269462A1 (en) 2007-11-22
GB2389112A (en) 2003-12-03
US20090074817A1 (en) 2009-03-19
US20090226462A1 (en) 2009-09-10
CA2467360A1 (en) 2002-05-23
CA2749307C (en) 2015-03-17
NO335842B1 (no) 2015-03-02
AU2002214891A1 (en) 2002-05-27
GB0313912D0 (en) 2003-07-23
GB2385854A (en) 2003-09-03
US7579011B2 (en) 2009-08-25
NO20032218D0 (no) 2003-05-15
AU2002223328A1 (en) 2002-05-27
US7851197B2 (en) 2010-12-14
WO2002040515A2 (en) 2002-05-23
US20050058662A1 (en) 2005-03-17
CA2707684A1 (en) 2002-05-23
CA2467309C (en) 2014-08-26
US20050158344A1 (en) 2005-07-21
NO20032217D0 (no) 2003-05-15
US7538208B2 (en) 2009-05-26
WO2002040514A3 (en) 2002-12-27
GB0313840D0 (en) 2003-07-23
CA2749307A1 (en) 2002-05-23
WO2002040515A3 (en) 2002-12-27
NO20032217L (no) 2003-07-09
CA2707684C (en) 2013-12-24
CA2467309A1 (en) 2002-05-23
CA2467360C (en) 2016-08-16
US20100008895A1 (en) 2010-01-14
US7232569B2 (en) 2007-06-19
US7351550B2 (en) 2008-04-01
NO20141517L (no) 2003-07-09
WO2002040514A2 (en) 2002-05-23
US7815896B2 (en) 2010-10-19

Similar Documents

Publication Publication Date Title
NO20021361D0 (no) Fremgangsmåte for rask og omfattende formasjonsevaluering
NO20011196L (no) Raffinorskivesensor og sensorraffinorskive
NO20032668L (no) Gyraseinhibitorer og anvendelser derav
DK1251848T3 (da) Gyraseinhibitorer og anvendelse deraf
NO20023216D0 (no) Instrumentert sementeringsplugg og system for samme
DK0813873T3 (da) Farmaceutisk sammensætning omfattende mirtazapin og en eller flere selektive serotingenoptagelseshæmmere
NO20020343D0 (no) Kaspase-inhibitorer og anvendelse derav
NO20014553D0 (no) Brönnplanlegging og konstruksjon
DK1268425T3 (da) Carbamatcaspaseinhibitorer og anvendelse deraf
DE60131797D1 (de) Spielsystem und entsprechendes computerlesbares Aufzeichungsmedium
NO20034405D0 (no) Anti-ostepontin-antistoff og anvendelse derav
DK1340062T3 (da) Metode og anordning til kryolagring
NO20015931D0 (no) Farmasöytiske formuleringer og fremgangsmåter som omfatter intranasal morfin
NO20015399D0 (no) System og fremgangsmåte for produktdemontering
EP1299337A4 (en) HYDROXYPHENSTATIN AND ITS PROMEDICATIONS
NO20011026D0 (no) Matvare og fremgangsmÕte for fremstilling derav
DK1068238T3 (da) Integrinheterodimer og subunit deraf
DE60045563D1 (de) Personenförderanlage
NO20032218D0 (no) Eksoenzymtoksin fra Aeromonas salmonicida og anvendelse derav
NO20023442L (no) N¶ringsmiddel og fremgangsmåte
PT1339695E (pt) Inibidores da farnesiltransferase
NO20030156D0 (no) Farmasöytiske sammensetninger og fremgangsmåter for anvendelse derav
EP1263767A4 (en) BETA NETRIN AND ITS USE
DE60103664D1 (de) Schwarzschulterklemmung
DK1406895T3 (da) Lactonformuleringer og fremgangsmåde til anvendelse deraf

Legal Events

Date Code Title Description
CREP Change of representative

Representative=s name: ZACCO NORWAY AS POSTBOKS 2003 VIKA OSLO, 0125 NO

MK1K Patent expired